Cite
APA Citation
Parrondo, R. D., Paulus, A., Alegria, V., Liebowitz, D., Johnson, C., Clynes, R., Roy, V., Menke, D. M., Jiang, L., Chanan-Khan, A. A., & Ailawadhi, S. (2022). plamotamab (XmAb®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia. Leukemia & lymphoma, 63(3), 738–742. http://access.bl.uk/ark:/81055/vdc_100152317959.0x000038